Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

Conditions:   Asthma;   Rhinovirus;   Picornaviridae Infections;   Common Cold
Interventions:   Drug: OC459;   Drug: Placebo;   Other: Rhinovirus
Sponsors:   Imperial College London;   Medical Research Council;   Atopix Therapeutics, Ltd.
Recruiting – verified January 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.